Life Science, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
PLoS One. 2012;7(7):e41369. doi: 10.1371/journal.pone.0041369. Epub 2012 Jul 19.
Statin- and exercise-therapy are both clinically beneficial by preventing cardiovascular events in patients with coronary artery disease (CAD). However, there is no information on the vascular effects of the combination of statins and exercise on arterial wall stiffness in CAD patients.
The present study is a sub-analysis of PRESET study that determined the effects of 20-week treatment with statins (rosuvastatin, n=14, atorvastatin, n=14) combined with regular exercise on arterial wall stiffness assessed by measurement of brachial and ankle pulse wave velocity (baPWV) in CAD patients.
The combination of statins and regular exercise significantly improved exercise capacity, lipid profile, including low- and high-density lipoprotein cholesterol, and high-sensitivity C-reactive protein (hs-CRP), baPWV (baseline: 1747 ± 355, at 20 weeks of treatment: 1627 ± 271 cm/s, p=0.008), and basophil count (baseline: 42 ± 32, 20 weeks: 26 ± 15 cells/µL, p=0.007), but had no effect on blood pressure (baseline: 125 ± 22, 20 weeks: 121 ± 16 mmHg). Changes in baPWV correlated significantly with changes in basophil count (r=0.488, p=0.008), but not with age, lipids profile, exercise capacity, or hs-CRP.
In CAD patients, the combination treatment with statins and exercise resulted in significant amelioration of arterial wall stiffness, at least in part, through reduction of circulating basophils.
他汀类药物治疗和运动疗法均可通过预防冠心病(CAD)患者的心血管事件而具有临床益处。然而,关于他汀类药物和运动联合治疗对 CAD 患者动脉壁僵硬的血管影响,尚无相关信息。
本研究是 PRESET 研究的一项亚分析,该研究旨在确定 20 周的他汀类药物(瑞舒伐他汀,n=14;阿托伐他汀,n=14)联合常规运动治疗对 CAD 患者动脉壁僵硬的影响,通过测量肱踝脉搏波速度(baPWV)来评估。
他汀类药物联合常规运动显著改善了运动能力、血脂谱,包括低和高密度脂蛋白胆固醇和高敏 C 反应蛋白(hs-CRP),baPWV(基线:1747±355,治疗 20 周时:1627±271cm/s,p=0.008)和嗜碱性粒细胞计数(基线:42±32,20 周时:26±15 细胞/µL,p=0.007),但对血压(基线:125±22,20 周时:121±16mmHg)没有影响。baPWV 的变化与嗜碱性粒细胞计数的变化显著相关(r=0.488,p=0.008),但与年龄、血脂谱、运动能力或 hs-CRP 无关。
在 CAD 患者中,他汀类药物联合运动治疗可显著改善动脉壁僵硬,至少部分通过降低循环嗜碱性粒细胞来实现。